Organon (OGN) reported $6.2B in revenue for fiscal 2025, −2.9% year on year. That ranks #702 by revenue among 2853 SEC filers and #60 in Healthcare. Net income was $187M, a net margin of 3.0%. Revenue has declined 3.7% a year on average since 2019 ($7.8B then). The fiscal 2025 balance sheet shows $12.9B in total assets, $574M in cash and $8.6B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $6.2B | −2.9% | FY20252025-12-31 |
| Gross profitGrossProfit | $3.3B | −10.8% | FY20252025-12-31 |
| Operating incomeIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $425M | −47.3% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $187M | −78.4% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $700M | −25.5% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $162M | −7.4% | FY20252025-12-31 |
| Total assetsAssets | $12.9B | −1.8% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $752M | +59.3% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $574M | −15.0% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $8.6B | −2.6% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $1.5B | $146M | Open → |
| Q2 20262026-06-30 | $1.6B | $108M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 99 of 161 companies compared | 3.0% | |
| Operating marginRank 100 of 160 companies compared | 6.8% | |
| R&D as share of revenueRank 68 of 102 companies compared | 5.9% | |
| Cash as share of revenueRank 92 of 160 companies compared | 9.2% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Organon & Co.
- Ticker
- OGN
- Exchange
- NYSE
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 12-31
- CIK
- 0001821825
Filings
- 10-QJul 31, 2026Open filing →
- 10-QMay 4, 2026Open filing →
- 10-KFeb 24, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| IconICLR | $8.3B | $229M |
| Zimmer BiometZBH | $8.2B | $705M |
| Ardent HealthARDT | $6.3B | $136M |
| OrganonOGN | $6.2B | $187M |
| Smith & NephewSNN | $6.2B | $625M |
| Edwards LifesciencesEW | $6.1B | $1.1B |
| SterisSTE | $5.9B | $782M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Organon — Key figures |url=https://companiesranked.com/en/company/organon |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Organon — Key figures. CompaniesRanked. https://companiesranked.com/en/company/organonBibTeX
@misc{companiesranked-en-company-organon-2026,
author = {{CompaniesRanked}},
title = {{Organon — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/organon}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-011125 · February 24, 2026
{{cite web |title=Organon — Key figures — 10-K (0001628280-26-011125) |url=https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.